Abstract
Chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease, cystic fibrosis, and lung cancer are among the leading causes of global mortality and morbidity, whereby these diseases have brought enormous healthcare, economic, and social burden in many countries. Multiple components of the respiratory system are affected by chronic respiratory diseases, which include the respiratory airways, lung parenchyma, as well as pulmonary vasculature. Recent advances in medical research have led to the development of various pharmacotherapeutic agents for the management of chronic respiratory diseases, such as bronchodilators, corticosteroids, and antibiotics. Despite that, the use of conventional therapeutics has been futile as they are only capable of alleviating the symptoms associated with the diseases but did not effectively cure or prevent the progression of these diseases. This chapter discusses the pathogenesis of various chronic respiratory disorders and the limitations of current therapeutic strategies.
| Original language | English |
|---|---|
| Title of host publication | Medicinal Plants for Lung Diseases |
| Subtitle of host publication | A Pharmacological and Immunological Perspective |
| Publisher | Springer Nature |
| Pages | 47-84 |
| Number of pages | 38 |
| ISBN (Electronic) | 9789813368507 |
| ISBN (Print) | 9789813368491 |
| DOIs | |
| State | Published - 1 Jan 2021 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Asthma
- Chronic obstructive pulmonary disease
- Chronic respiratory diseases
- Cystic fibrosis
- Interstitial lung disease
- Lung cancer
- Tuberculosis
Fingerprint
Dive into the research topics of 'Introduction to Chronic Respiratory Diseases: A Pressing Need for Novel Therapeutic Approaches'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver